By Kuda Pembere Having received 2000 doses of Cabotegravir (CAB-LA), a long-acting injectable pre-exposure prophylaxis (PrEP), Zimbabwe’s Ministry of Health and Child Care says they will roll it out next year. Speaking at a Health Communicators Forum (HCF) media science café, a MoHCC officer in the AIDS and TB department Dr Idah Moyo said the product is currently being assessed at demonstration sites in the country. So of note is that the Cabotegravir long-acting injection pre-exposure prophylaxis is being delivered under the demonstration site and is coming in according to…
Read MoreTag: INJECTABLE PREP
Zim ready for long term injectable PrEP-MoHCC
IN a bid to increase adherence to Antiretroviral Therapy (ART) in Zimbabwe, the Ministry of Health and Child Care (MoHCC) said it welcomes obtaining studies to advance prevention therapy through long term injectable Pre-Exposure prophylaxes medications. By Staff Reporter This follows the approval of Apretude (cabotegravir extended-release injectable suspension) in 2021 by the U.S. Food and Drug Administration. This will be taken in at-risk adults and adolescents weighing at least 35 kilograms (77 pounds) for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV. However, in Zimbabwe, current…
Read More